These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1422082)

  • 1. [New possibilities in diagnosis of hemolytic diseases in newborns].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):208-13. PubMed ID: 1422082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New possibilities in diagnosing hemolytic disease of newborn infants].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Beitr Infusionsther; 1992; 30():431-5. PubMed ID: 1284753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the affinity of anti-D in the serum of immunized mothers and in immunoglobulin preparations with unlabeled antibodies.
    Debbia M; Brossard Y; Lambin P
    Transfusion; 2005 Jun; 45(6):975-83. PubMed ID: 15934997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother.
    Wang M; Hays T; Ambruso DR; Silliman CC; Dickey WC
    Pediatr Blood Cancer; 2005 Nov; 45(6):861-2. PubMed ID: 16007582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum ABO immune antibodies in 1944 pregnant women].
    Wan MR
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):12-4, 60-1. PubMed ID: 1900749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic disease of the newborn due to ABO incompatibility. A predictive test].
    Arévalo C; Herrmann F; Aguirre E; Vera J
    Rev Med Chil; 1992 Feb; 120(2):163-7. PubMed ID: 1340554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.
    Li P; Pang LH; Liang HF; Chen HY; Fan XJ
    Fetal Pediatr Pathol; 2015; 34(6):341-50. PubMed ID: 26359685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rhesus erythroblastosis, monitoring and treatment].
    Siebers JW; Rasenack R; Hillemanns HG
    Zentralbl Gynakol; 1985; 107(20):1226-42. PubMed ID: 3934880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement-activating capacity of maternal IgG antibodies to blood group A in paired mother/child serum samples.
    Hari Y; von Allmen EC; Boss GM; Naiem A; Gittermann M; Nydegger UE
    Vox Sang; 1998; 74(2):95-100. PubMed ID: 9501407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of neonatal ABO immunization which was difficult to diagnose. The mother with blood group A2 and the infant with negative direct antiglobulin test].
    Kumlien G; Sarman I; Shanwell A
    Lakartidningen; 2000 Sep; 97(38):4138-40. PubMed ID: 11068380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.